1. Home
  2. TUYA vs MDXG Comparison

TUYA vs MDXG Comparison

Compare TUYA & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tuya Inc. each representing one

TUYA

Tuya Inc. each representing one

HOLD

Current Price

$2.31

Market Cap

1.3B

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$3.85

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TUYA
MDXG
Founded
2014
2006
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.0B
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
TUYA
MDXG
Price
$2.31
$3.85
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$3.49
$10.00
AVG Volume (30 Days)
1.1M
884.2K
Earning Date
05-19-2026
04-29-2026
Dividend Yield
5.19%
N/A
EPS Growth
N/A
14.29
EPS
N/A
0.32
Revenue
N/A
$418,630,000.00
Revenue This Year
$13.76
N/A
Revenue Next Year
$11.90
$13.02
P/E Ratio
$27.45
$12.09
Revenue Growth
N/A
19.99
52 Week Low
$1.87
$3.77
52 Week High
$2.95
$7.99

Technical Indicators

Market Signals
Indicator
TUYA
MDXG
Relative Strength Index (RSI) 46.28 26.77
Support Level $2.24 $3.77
Resistance Level $2.46 $7.39
Average True Range (ATR) 0.10 0.15
MACD -0.01 0.01
Stochastic Oscillator 33.33 14.84

Price Performance

Historical Comparison
TUYA
MDXG

About TUYA Tuya Inc. each representing one

Tuya Inc is an AI cloud platform service provider dedicated to bringing AI into everyday life. The group leverages its TuyaOpen open-source framework and universal AI Agent engines, including the AI Agent development platform, to integrate multimodal AI capabilities and reduce barriers to AI development. It drives the adoption of AI-powered lifestyles and speeds up the integration of AI with the physical world. It offers innovative physical AI solutions for smart devices, commercial use, and industry developers using cloud computing and spatial intelligence. It also provides a complete, open, and neutral global AIoT ecosystem. It builds a developer community that collaborates to create smart solutions grounded in sustainability, security, efficiency, agility, and openness.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: